Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death

@article{Wang2006MultipleBF,
  title={Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death},
  author={T. Wang and P. Gona and M. G. Larson and G. Tofler and D. Levy and C. Newton‐Cheh and P. Jacques and N. Rifai and J. Selhub and S. Robins and Emelia J Benjamin and R. D'Agostino and Ramachandran S. Vasan},
  journal={The New England Journal of Medicine},
  year={2006},
  volume={355},
  pages={2631-2639}
}
  • T. Wang, P. Gona, +10 authors Ramachandran S. Vasan
  • Published 2006
  • Medicine
  • The New England Journal of Medicine
    • BACKGROUND: Few investigations have evaluated the incremental usefulness of multiple biomarkers from distinct biologic pathways for predicting the risk of cardiovascular events. METHODS: We measured 10 biomarkers in 3209 participants attending a routine examination cycle of the Framingham Heart Study: the levels of C-reactive protein, B-type natriuretic peptide, N-terminal pro-atrial natriuretic peptide, aldosterone, renin, fibrinogen, D-dimer, plasminogen-activator inhibitor type 1, and… CONTINUE READING
    View PDF
    479 Citations
    Highly Influencial Citations
    2
    Background Citations
    35
    Methods Citations
    5
    Results Citations
    6
    479 Citations
    Citation Type

    Citation Type

    Multiple Biomarkers for Risk Prediction in Chronic Heart Failure
    • 159
    • PDF
    Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study).
    • 13
    Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study.
    • 25
    N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study.
    • 41
    Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    • 16
    Clinical Use of Serum Biomarkers in the Prediction of Cardiovascular Risk
    • 2
    Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study.
    • 11
    Evaluation of 9 biomarkers for predicting 10-year cardiovascular risk in patients undergoing coronary angiography: findings from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study.
    • 9
    • PDF
    Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure.
    • 4
    • PDF
    Biomarkers for prediction of cardiovascular events.
    • 22

    References

    SHOWING 1-10 OF 46 REFERENCES
    Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
    • 265
    Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    • 854
    • PDF
    N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    • 370
    • PDF
    An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.
    • 383
    • PDF
    C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
    • 2,775
    C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    • 239
    • PDF
    Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.
    • 430
    • PDF
    Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.
    • 241
    • PDF
    Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis
    • 333
    C-Reactive Protein as a Predictor of Cardiovascular Risk in a Population With a High Prevalence of Diabetes: The Strong Heart Study
    • 91